Clinical Trials Directory

Trials / Completed

CompletedNCT02097420

HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve

HALO Clinical Study: A Single Arm, Prospective, Non-randomized, Multi Center Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Abbott Medical Devices · Industry
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to provide evidence of safety and effectiveness of the study valve. The rationale is to offer a replacement mitral valve for patients with anatomy that is too small for the currently commercially available valves ranging in size from 16mm to 37mm. 20 subjects were enrolled as part of the IDE cohort and an additional 3 were enrolled under continued access.

Detailed description

The study is a single arm, prospective, non-randomized, multi-center clinical investigation. The objective of this study is to evaluate the safety and effectiveness of the 15mm MHV in subjects five years or less of age with a diseased, damaged, or malfunctioning mitral heart valve. The objective will be evaluated by assessing valve-related adverse events, subject survival, subject growth, and echocardiogram assessment of hemodynamic function through the five year follow-up visit as long as the valve remains implanted.

Conditions

Interventions

TypeNameDescription
DEVICEMitral valve replacement SJM™ Masters HP™ 15mm Rotatable Mechanical Heart ValveImplantation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve in the mitral and aortic positions

Timeline

Start date
2015-05-07
Primary completion
2019-03-01
Completion
2023-07-01
First posted
2014-03-27
Last updated
2025-02-11
Results posted
2020-06-02

Locations

24 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02097420. Inclusion in this directory is not an endorsement.